St-Pieters Leeuw, Belgium

Jean-Paul Van Vooren


Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 1999-2007

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Jean-Paul Van Vooren

Introduction: Jean-Paul Van Vooren, a prominent inventor based in St-Pieters Leeuw, Belgium, has made significant strides in the field of biotechnology. With four patents to his name, his work is primarily focused on recombinant polypeptides and peptides, particularly in relation to tuberculosis diagnostics and vaccine development.

Latest Patents: Among his latest inventions, Van Vooren has developed recombinant polypeptides and peptides that contain specific amino acid sequences crucial for diagnostic applications. These inventions include novel polypeptides that can aid in diagnosing tuberculosis and serve as active principles in vaccine preparation against the disease. The detailed sequences extend from nucleotide position (1) to position (194), underlining the precision and complexity of his work.

Career Highlights: Van Vooren is currently associated with N.V. Innogenetics S.A., where he continues to push the boundaries of biotechnological research and innovation. His role in the company has been pivotal in advancing new therapeutic solutions in infectious diseases, notably tuberculosis.

Collaborations: Throughout his career, Van Vooren has collaborated with notable coworkers including Jean Content and Lucas De Wit. These partnerships have enhanced his research efforts and contributed to the success of his innovative projects.

Conclusion: Jean-Paul Van Vooren exemplifies the spirit of innovation in the biotechnology sector. His patents not only showcase his inventiveness but also highlight his commitment to advancing medical science, particularly in the fight against tuberculosis. As research continues, Van Vooren's contributions are likely to pave the way for more effective diagnostic tools and vaccines.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…